Tech Company M&A Transactions
Micrus Endovascular Acquisition
Headquartered in San Jose, Micrus Endovascular was acquired by Johnson & Johnson. The parties disclosed the acquisition price to be $480 million.
Transaction Overview
Company Name
Acquired By
Announced On
7/12/2010
Transaction Type
M&A
Amount
$480,000,000
M&A Terms
Under the terms of the agreement, Micrus Endovascular stockholders will receive at closing $23.40 for each outstanding Micrus Endovascular share. The value of the transaction as of the anticipated closing date is estimated to be approximately $480 million, based upon Micrus Endovascular's 20.5 million fully diluted shares outstanding.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
821 Fox Lane
San Jose, CA 95131
USA
San Jose, CA 95131
USA
Phone
Website
Email Address
Overview
Micrus Endovascular manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Our products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms in the brain responsible for hemorrhagic stroke, a significant cause of death in the United States.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 7/11/2010: DocuSign venture capital transaction
Next: 7/12/2010: EcoMotors venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs